About: David C Linch

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: David C Linch Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	researcher (en) 연구원 (ko) 研究者 (ja) дослідник (uk) հետազոտող (hy) onderzoeker (nl)
rdfs:label	David C Linch (en) David C Linch (nl) David C. Linch (cs)
skos:prefLabel	David C Linch (en) David C Linch (nl) David C. Linch (cs)
name	David C Linch (en) David C Linch (nl) David C. Linch (cs)
given name	wds:Q89467453-57B76D6E-DD8D-4AD2-8DFB-5773D00D2D3A
given name	David
instance of	wds:Q89467453-71A9868F-154B-41A6-82FE-DF12F50CFFE1
NL CR AUT ID	wds:Q89467453-7C2467C2-6FEC-4C64-969F-43EE3112AB98
instance of	Homo sapiens
NL CR AUT ID	nlk20040160839
skos:altLabel	David Linch (en)
occupation	wds:Q89467453-27578FDC-ACAD-4734-8B14-E6425F494F90
sex or gender	wds:Q89467453-B38B6CA1-640F-45F1-9450-FCAE0D278A41
VIAF ID	wds:Q89467453-1CFA78A7-1C18-42C8-AE0D-72DAF53561CA
Library of Congress authority ID	wds:Q89467453-0485bd56-41a7-ce15-fa28-ff64f97371f1
IdRef ID	wds:Q89467453-fe53533a-ba8c-4cb3-a805-b392e07343fe
National Library of Israel J9U ID	wds:Q89467453-89622F64-3E04-4719-8746-356FAA0E7BED
VIAF ID	http://viaf.org/viaf/21102892
Library of Congress authority ID	http://id.loc.gov/authorities/names/n85029379
IdRef ID	http://www.idref.fr/077193873/id
occupation	researcher
sex or gender	male
VIAF ID	21102892
Library of Congress authority ID	n85029379
IdRef ID	077193873
National Library of Israel J9U ID	987007369360005171
ORCID iD	wds:Q89467453-AB11624F-DE37-4BB4-92D8-6B26B204B26F
ORCID iD	https://orcid.org/0000-0002-9988-5528
ORCID iD	0000-0002-9988-5528
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q89467453
is author of	Acquired skewing of X-chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age. Lack of pathogenic mutations in the 5'-untranslated region of the thrombopoietin gene in patients with non-familial essential thrombocythaemia RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years The prognostic significance of IDH2 mutations in AML depends on the location of the mutation The prognostic significance of IDH1 mutations in younger adult patients with acute myeloid leukemia is dependent on FLT3/ITD status ASXL1 mutations are infrequent in young patients with primary acute myeloid leukemia and their detection has a limited role in therapeutic risk stratification Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphoma Investigation Clinical significance of the haemopoietic growth factors Final analysis of the UKLG LY02 trial comparing 6-8 cycles of CHOP with 3 cycles of CHOP followed by a BEAM autograft in patients <65 years with poor prognosis histologically aggressive NHL. High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution Studies of circulating hemopoietic progenitor cells in human fetal blood c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value Treatment of the elderly patient with diffuse large B cell lymphoma The polymerase chain reaction in the demonstration of monoclonality in T cell lymphomas Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment Dynamic modulation of the cell surface expression of the granulocyte-macrophage colony-stimulating factor receptor A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications Adenovirus-associated virus vector-mediated gene transfer in hemophilia B Cyclin C is a haploinsufficient tumour suppressor G6PC3 mutations are associated with a major defect of glycosylation: a novel mechanism for neutrophil dysfunction Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations. Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working Party Development of antibodies to unprotected glycosylation sites on recombinant human GM-CSF Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: ... The role of allogeneic transplantation in non-Hodgkin's lymphoma In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma Investigation of early T cell activation: analysis of the effect of specific antigen, interleukin 2 and monoclonal antibodies on intracellular free calcium concentration The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials. Novel regions of acquired uniparental disomy discovered in acute myeloid leukemia Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients High-dose cyclophosphamide with autologous marrow transplantation for small cell carcinoma of the bronchus Hodgkin's Lymphoma: Choice of Therapy and Late Complications. High-dose cyclophosphamide with autologous marrow transplantation as initial treatment of small cell carcinoma of the bronchus WT1 mutations in T-ALL Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a British National Lymphoma Investigation double-blind, placebo-controlled trial Frequency of CBF beta/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials. The MRC Adult Leukaemia Working Party Successful pregnancies in women following single autotransplant for acute myeloid leukemia with a chemotherapy ablation protocol Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial EVI1 expression in acute myeloid leukaemia Feasibility of multidrug resistance (MDR-1) gene transfer in patients undergoing high-dose therapy and peripheral blood stem cell transplantation for lymphoma Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARalpha, AML1/ETO and CBFB/MYH11 respectively in acute myeloid leukaemia. MRC Adult Leukaemia Working Party. Medical Research Council. Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software